Souhaitez-vous accéder aux communiqués récents ?

sNDA submitted seeking approval of IGALMI® in the at-home (outpatient) setting for the treatment of acute agitation associated with bipolar disorders or schizophrenia sNDA submission timeline...

Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Completed a US$57.2 million equity financing; commenced trading on the Nasdaq Global Market under the ticker “MSLE” on Feb. 6, 2026 Secured global regulatory clearances and initiated BASECAMP, a...

Record Quarterly Revenues of $737.6 Million, a 34.6% Increase from a Year Ago Quarterly Adjusted EBITDA (non-GAAP) Increased 53% from Prior Year1 Record Total Backlog and Awards of $3.7 Billion, 49%...

Autolus announces its operational and financial results for the fourth quarter and full year ended December 31, 2025.

WATERTOWN, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of...

CREDIT AGRICOLE DU MORBIHAN  PUBLICATION DU RAPPORT FINANCIER ANNUEL 2025 La Caisse Régionale de Crédit Agricole du Morbihan annonce la publication de son Rapport Financier Annuel 2025 sur le site...

Unipart has today announced its full year results for 2025, a year defined by successful strategic transition, expansion and continued momentum.

SHENZHEN, China, March 27, 2026 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance...

Communiqué de Presse Exercice 2025 Résultats opérationnels estimés Vantiva atteint ses objectifs à taux de change budgétaireEBITDA ajusté : 145 M€(1) contre 109 M€ en 2024¹(155 M€ à taux de change...